Molecule Name |
PE000909
|
Refractivity |
75
|
SMILES format |
OC1=CC=C(C=C1)C1=COC2=CC3=C(OCO3)C(O)=C2C1=O
|
Resonant Structures |
200
|
TPSA |
85
|
ASA hydrophobic |
277
|
ASA polar |
172
|
Accessible Surface Area |
450
|
LogS |
-4
|
MW |
298
|
cLogP |
2
|
H-Acceptors |
6
|
H-Donors |
2
|
Ro5 violations |
0
|
DrugScore |
0
|
Druglikeness |
0
|
Irritant |
none
|
Mutagenic |
none
|
Reproductive Effective |
high
|
Tumorigenic |
none
|
Fish Toxicity |
High FHMT
|
Fish Toxicity 2 |
0.7529
|
Rat Acute Toxicity |
3
|
Acute Oral Toxicity |
III
|
Caco-2 Permeability |
Caco2-
|
Caco-2 Permeability 2 |
1
|
P-glycoprotein Substrate |
Non-substrate
|
P-glycoprotein Inhibitor |
Non-inhibitor
|
P-glycoprotein Inhibitor 2 |
Non-inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition 2 |
Non-inhibitor
|
CYP450 2C9 Substrate |
Non-substrate
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity 2 |
0
|
AMES Toxicity |
Non AMES toxic
|
CYP450 3A4 Inhibitor |
Inhibitor
|
CYP450 3A4 Substrate |
Non-substrate
|
CYP450 2C19 Inhibitor |
Inhibitor
|
CYP450 2C9 Inhibitor |
Inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 1A2 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Substrate |
Non-substrate
|
Biodegradation |
Not ready biodegradable
|
Carcinogens |
Non-carcinogens
|
Blood-Brain Barrier |
BBB+
|
CYP Inhibitory Promiscuity |
High CYP Inhibitory Promiscuity
|
Honey Bee Toxicity |
High HBT
|
Renal Organic Cation Transporter |
Non-inhibitor
|
Carcinogenicity (Three-class) |
Non-required
|
Human Intestinal Absorption |
HIA+
|